Market revenue in 2020 | USD 60.8 million |
Market revenue in 2027 | USD 104.9 million |
Growth rate | 8.1% (CAGR from 2020 to 2027) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Instruments |
Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.45% in 2020. Horizon Databook has segmented the Mexico blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
The Mexico blood transfusion diagnostics market is an emerging market. Obtaining blood for transfusion is a potential challenge in the healthcare sector of developing countries. The supply of contaminated units increases the chances of mortality, morbidity, and the cost for patients.
In Mexico, serological screening is mandatory, however, only selective blood banks regularly perform a Nucleic Acid Test (NAT). According to WHO, Mexico is categorized as an upper-middle-income country with a complex healthcare system. The blood supply is maintained by over 550 blood banks across the country.
The state of Jalisco, Mexico, is the key supplier of Central Blood Bank of the National Western Medical Center and records on an average 68,000 donations per year. From 2021, the Center of the Mexican Social Security Institute has made NAT an internal policy along with serological screening for all blood donations.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico blood transfusion diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into Mexico blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account